A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-1010
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients ; volume:32 ; number:1 ; day:20 ; month:7 ; year:2022 ; pages:1-11 ; date:12.2022
npj Primary care respiratory medicine ; 32, Heft 1 (20.7.2022), 1-11, 12.2022
- Creator
-
Patel, Smit
Dickinson, Scott
Morris, Kevin
Ashdown, Helen F.
Chalmers, James D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41533-022-00288-6
- URN
-
urn:nbn:de:101:1-2022100422092023790815
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Patel, Smit
- Dickinson, Scott
- Morris, Kevin
- Ashdown, Helen F.
- Chalmers, James D.
- SpringerLink (Online service)
Other Objects (12)
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study
A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma
Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype – a randomized controlled trial study protocol
Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study
A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma
Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype – a randomized controlled trial study protocol
Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
Inhaled corticosteroids in COPD and the risk for coronary heart disease: a nationwide cohort study
A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis
Overuse of Oral Corticosteroids, Underuse of Inhaled Corticosteroids, and Implications for Biologic Therapy in Asthma
Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype – a randomized controlled trial study protocol
Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD